Skip to main content
. 2017 Apr 11;11:100. doi: 10.1186/s13256-017-1272-9

Table 2.

Summary of paclitaxel, ifosfamide, carboplatin, and etoposide therapy cycles given to our patient

Cycles Frequency Days
1–2 Every 14 days D 1: paclitaxel 250 mg/m2 IV over 24 hours
D 2–4: ifosfamide 2000 mg/m2 IV + mesna support
D 4–14: GCSF 10 mcg/kg per day
D 11–14: stem cell collection (28×106/kg CD34+ cells collected)
3–5 Every 21 days D 1–3: carboplatin AUC = 8 IV + etoposide 400 mg/m2 IV
D 5: stem cell infusion (9.65×106/kg CD34+ cells with each cycle)
D 3–21: GCSF 10mcg/kg per day

AUC area under the concentration-time curve, D days, GCSF granulocyte-colony stimulating factor, IV intravenous